Equities

Shaanxi Meibang Pharmaceutical Group Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Shaanxi Meibang Pharmaceutical Group Co Ltd

Actions
Basic MaterialsChemicals
  • Price (CNY)28.67
  • Today's Change2.61 / 10.02%
  • Shares traded2.75m
  • 1 Year change+38.37%
  • Beta1.0195
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Shaanxi Meibang Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the research and development, production and sales of pesticide products, as well as the promotion and service of agricultural technology. The Company's raw material varieties include copper quinoline, fenacitrile, bufluron and other products. The formulation products mainly include insecticides, fungicides, plant growth regulators, and others. The Company's products are mainly used in fields, fruits, vegetables, flowers and other crops. The Company mainly conducts business in the domestic market.

  • Revenue in CNY (TTM)871.63m
  • Net income in CNY29.78m
  • Incorporated1998
  • Employees998.00
  • Location
    Shaanxi Meibang Pharmaceutical Group Co LtdHigh-Tech Industrial Development ZonePucheng County,XI'AN 715500ChinaCHN
  • Phone+86 2 986183766
  • Fax+86 2 989820615
  • Websitehttp://www.meibang.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Wuxi Acryl Technology Co Ltd439.05m-29.26m3.77bn274.00--3.95--8.58-0.302-0.3024.549.770.4010.446.361,602,377.00-2.706.11-3.377.713.4921.04-6.768.752.57--0.0043.19-13.14-1.58-182.15--30.72-19.73
Kente Catalysts Inc619.41m89.01m3.79bn552.0042.553.22--6.120.98460.98466.8513.01----------------27.95--14.37--5.91--0.001---7.40--9.73------
Jiangsu Hengxing New MaterilTchnlgyCoLtd771.90m40.80m3.80bn422.0093.222.18--4.920.19630.19633.668.390.41623.7810.341,829,149.002.20--2.31--16.19--5.29--7.38--0.0258--13.37---55.36------
Suli Co Ltd2.73bn119.78m3.82bn1.83k33.791.44--1.400.60550.605513.5514.200.48034.975.651,494,286.002.043.992.956.1917.1219.124.247.841.704.420.281931.5917.914.96-154.03--12.75--
Jiangsu Jiangnan High Polymer Fiber534.12m27.93m3.84bn339.00137.291.86--7.200.01620.01620.30991.190.24321.6024.651,575,583.001.274.071.304.228.3817.485.2311.948.62--0.005127.27-34.09-14.05-17.23-14.29-49.85-9.71
Shaanxi Meibang Pharmaceuticl Grp Co Ltd871.63m29.78m3.88bn998.00130.163.38--4.450.22030.22036.458.490.4763.485.25873,380.501.636.562.169.3629.7134.353.4211.381.66--0.115618.4226.6811.42-35.96-13.5336.28--
Crown Advanced Material Co Ltd640.01m-126.92m3.89bn419.00--1.46--6.07-0.6839-0.68393.3213.190.21436.733.391,527,476.00-4.252.06-4.632.51-7.1912.64-19.834.269.88--0.0131222.10-38.13-1.79-180.95--2.81--
Shan Dong Lu Bei Chemical Co Ltd5.51bn67.24m3.96bn2.79k58.881.24--0.71880.12720.127210.426.060.60876.0921.501,972,024.001.764.374.279.298.2912.952.896.310.8411136.480.467715.8915.0615.73157.283.0123.08--
Shanghai Titan Scientific Co Ltd2.61bn14.35m3.96bn1.83k279.051.42--1.520.08640.086415.6616.980.53641.873.531,426,386.000.07272.920.10834.0521.6220.800.13553.891.271.050.341934.784.1120.31-82.23-29.5275.53--
Data as of Feb 13 2026. Currency figures normalised to Shaanxi Meibang Pharmaceutical Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Lion Fund Management Co., Ltd.as of 30 Jun 2025423.000.00%
Bank of Communications Schroder Fund Management Co., Ltd.as of 30 Jun 2025126.000.00%
New China Fund Management Co., Ltd.as of 30 Jun 202523.000.00%
ICBC UBS Asset Management Co. Ltd.as of 30 Jun 20250.000.00%
China Universal Asset Management Co., Ltd.as of 30 Jun 20250.000.00%
JPMorgan Asset Management (China) Co Ltd.as of 30 Jun 20250.000.00%
Cinda Fund Management Co. Ltd.as of 30 Jun 20250.000.00%
Zhong Ou Asset Management Co., Ltdas of 30 Jun 20250.000.00%
CITIC Securities Co., Ltd. (Invt Port)as of 30 Jun 20250.000.00%
Jiangxin Fund Management Co., Ltd.as of 30 Jun 20250.000.00%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.